Close
Digital Health & Ai Innovation summit 2026
APE 2026

Research Insight

Dr Tan Yew Oo; A new activist for treating oncology in Singapore

When Dr Tan Yew Oo introduced himself as a medical oncologist in 1978, even fellow doctors in Singapore barely knew what that meant. Dr Tan, who...

Medtronic CEO and chairman Omar Ishrak to make a formal presentation on the company at CEO Investor Forum 3.0

Medtronic plc , the global leader in medical technology announced it will participate in the CECP CEO Investor Forum 3.0 in New York on Monday,...

Medtronic’s pediatric study: Minimed(TM) 670G shows positive results among children aged 7 to 13

Medtronic plc , the global leader in medical technology announced that new data from its at-home pediatric study of the MiniMed(TM) 670G system in patients...

Austin Area Obstetrics, Gynecology and Fertility Completes Successful First Year of Clinical Research

Since it started offering patients the opportunity to participate in clinical research a year ago, Austin Area Obstetrics, Gynecology and Fertility has provided research opportunities...

Compound designed to fight Alzheimer’s disease shows promise in the lab

The year was 1906, and German physician Alois Alzheimer was examining the brain of a patient who had died after a battle with progressive dementia. The...

Long-term protection against HIV : Gene therapy using CAR T cells

A UCLA-led research team has created blood-forming stem cells that can carry a gene that allows the body to produce cells that can detect and...

Phase 3 PROSPER Trial Shows XTANDI Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer

Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Pfizer Inc. (NYSE: PFE) announced today results from the Phase 3 PROSPER trial...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »